Imaging of Neuroinflammation in Neurodegenerative Diseases (INMiND)
At a Glance
- Status: Active Consortium
- Year Launched: 2012
- Initiating Organization: European Commission Seventh Framework Programme (FP7)
- Initiator Type: Government
- Disease focus:
- Location: Europe
The goal of the Imaging of Neuroinflammation in Neurodegenerative Diseases (INMiND) consortium is to identify novel biological targets of neuroinflammation for diagnostic and therapeutic purposes and to translate this knowledge into clinical application and patient benefit. INMiND supports collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration.
INMiND’s goal is to carry out collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration in order to identify novel biological targets for activated microglia, which may serve diagnostic and therapeutic purposes, and to translate this knowledge into the clinic. Its main aims are as follows:
INMiND receives funding from the European Union’s Seventh Framework Programme, via Project No. 278850. The European Commission’s contribution is €12.0 million.
Sponsors & Partners
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15
phone: +49 251 83 49300
fax: +49 251 83 49313